bullish

Dalmia Bharat

Dalmia Bharat: Healthy Operating Performance; New Capex To Provide Growth Thrust

171 Views30 Jul 2021 11:31
Broker
We maintain our BUY rating on the stock, valuing the company at 13x FY23E EV/EBITDA, to arrive at a target price of Rs 2,370/share, implying an upside of 10% from the CMP.
SUMMARY
(Sign Up to Access)
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
  • Unlock all research summaries
  • Follow top, independent analysts
  • Receive personalised alerts and emails
  • Access Briefings, Analytics, and Events

Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.

Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 1-minute read)
Discussions
(Paid Plans Only)
chart-bar
Logo
Axis Direct
External broker reports(aggregated public sources)
Axis Direct
IndiaEquity Bottom-Up
  • Dalmia Bharat: Healthy Operating Performance; New Capex To Provide Growth Thrust
    30 Jul 2021
x